Katerina Benesova
Prague, PR, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Long-Term Real-World Outcomes of Primary CNS Lymphoma Patients Treated With MATRix Regimen Are Similar to IELSG32 Trial Results.
Journal: Hematological oncology
Published: July 08, 2025
Circulating tumour DNA as a predictor of survival of patients with diffuse large B-cell lymphoma in a daily practice.
Journal: British journal of haematology
Published: May 29, 2025
The journey of patients with diffuse large B-cell lymphoma: from symptoms to diagnosis.
Journal: Leukemia & lymphoma
Published: March 31, 2025
Risk of central nervous system versus systemic relapse in patients with diffuse large B-cell lymphoma treated with R-CHOP: What should we focus on?
Journal: HemaSphere
Published: March 21, 2025
Oral, not gut microbiota diversity, reflects the inflammation and neoplasia in patients with uveitis and vitreoretinal lymphoma.
Journal: Journal of ophthalmic inflammation and infection
Published: October 01, 2024
Whole-body magnetic resonance imaging provides accurate staging of diffuse large B-cell lymphoma, but is less preferred by patients.
Journal: World journal of radiology
Published: July 16, 2024
Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy.
Journal: American journal of hematology
Published: May 18, 2023
Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic.
Journal: Annals of hematology
Published: August 08, 2022
Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma in the real world.
Journal: European journal of haematology
Published: January 02, 2022
Last Updated: 09/26/2026